Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 SV119-gold nanocage conjugates: a new platform for targeting cancer cells via sigma-2 receptors.

Literature DB >> 22113350

SV119-gold nanocage conjugates: a new platform for targeting cancer cells via sigma-2 receptors.

Yucai Wang¹, Jinbin Xu, Xiaohu Xia, Miaoxin Yang, Suwanna Vangveravong, Jingyi Chen, Robert H Mach, Younan Xia.

Abstract

We have functionalized the surface of gold nanocages with SV119, a synthetic small molecule specific to sigma-2 receptors, and then demonstrated the capability of this new class of conjugates for targeting cancer cells.

Entities: CellLine Chemical Disease Gene Species

Mesh：

Substances：

Year: 2011 PMID： 22113350 PMCID： PMC4600571 DOI： 10.1039/c1nr11469g

Source DB: PubMed Journal: Nanoscale ISSN： 2040-3364 Impact factor: 7.790

17 in total

1. Immuno gold nanocages with tailored optical properties for targeted photothermal destruction of cancer cells.

Authors: Jingyi Chen; Danling Wang; Jiefeng Xi; Leslie Au; Andy Siekkinen; Addie Warsen; Zhi-Yuan Li; Hui Zhang; Younan Xia; Xingde Li
Journal: Nano Lett Date: 2007-04-13 Impact factor: 11.189

2. Subcellular localization of sigma-2 receptors in breast cancer cells using two-photon and confocal microscopy.

Authors: Chenbo Zeng; Suwanna Vangveravong; Jinbin Xu; Katherine C Chang; Richard S Hotchkiss; Kenneth T Wheeler; Duanwen Shen; Zhi-Ping Zhuang; Hank F Kung; Robert H Mach
Journal: Cancer Res Date: 2007-07-15 Impact factor: 12.701

Review 3. Development of molecular probes for imaging sigma-2 receptors in vitro and in vivo.

Authors: Robert Henry Mach; Kenneth Theodore Wheeler
Journal: Cent Nerv Syst Agents Med Chem Date: 2009-09

4. A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands.

Authors: Xiaohua Huang; Xianghong Peng; Yiqing Wang; Yuxiang Wang; Dong M Shin; Mostafa A El-Sayed; Shuming Nie
Journal: ACS Nano Date: 2010-10-26 Impact factor: 15.881

5. Enhanced anticancer activity of multi-walled carbon nanotube-methotrexate conjugates using cleavable linkers.

Authors: Cristian Samorì; Hanene Ali-Boucetta; Raquel Sainz; Chang Guo; Francesca Maria Toma; Chiara Fabbro; Tatiana da Ros; Maurizio Prato; Kostas Kostarelos; Alberto Bianco
Journal: Chem Commun (Camb) Date: 2009-12-23 Impact factor: 6.222

Review 6. Sigma receptor ligands: possible application as therapeutic drugs and as radiopharmaceuticals.

Authors: Kenji Hashimoto; Kiichi Ishiwata
Journal: Curr Pharm Des Date: 2006 Impact factor: 3.116

7. Facile synthesis of Ag nanocubes and Au nanocages.

Authors: Sara E Skrabalak; Leslie Au; Xingde Li; Younan Xia
Journal: Nat Protoc Date: 2007 Impact factor: 13.491

8. Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site.

Authors: Jinbin Xu; Chenbo Zeng; Wenhua Chu; Fenghui Pan; Justin M Rothfuss; Fanjie Zhang; Zhude Tu; Dong Zhou; Dexing Zeng; Suwanna Vangveravong; Fabian Johnston; Dirk Spitzer; Katherine C Chang; Richard S Hotchkiss; William G Hawkins; Kenneth T Wheeler; Robert H Mach
Journal: Nat Commun Date: 2011-07-05 Impact factor: 14.919

9. The novel sigma-2 receptor ligand SW43 stabilizes pancreas cancer progression in combination with gemcitabine.

Authors: John R Hornick; Jinbin Xu; Suwanna Vangveravong; Zhude Tu; Jonathan B Mitchem; Dirk Spitzer; Peter Goedegebuure; Robert H Mach; William G Hawkins
Journal: Mol Cancer Date: 2010-11-22 Impact factor: 27.401

10. Sigma-2 receptor ligands potentiate conventional chemotherapies and improve survival in models of pancreatic adenocarcinoma.

Authors: Hiroyuki Kashiwagi; Jonathan E McDunn; Peter O Simon; Peter S Goedegebuure; Suwanna Vangveravong; Katherine Chang; Richard S Hotchkiss; Robert H Mach; William G Hawkins
Journal: J Transl Med Date: 2009-03-26 Impact factor: 5.531

11 in total

1. Research perspectives: gold nanoparticles in cancer theranostics.

Authors: Junjie Li; Sanjay Gupta; Chun Li
Journal: Quant Imaging Med Surg Date: 2013-12

Review 2. Nanocaged platforms: modification, drug delivery and nanotoxicity. Opening synthetic cages to release the tiger.

Authors: Mahdi Karimi; Parham Sahandi Zangabad; Fatemeh Mehdizadeh; Hedieh Malekzad; Alireza Ghasemi; Sajad Bahrami; Hossein Zare; Mohsen Moghoofei; Amin Hekmatmanesh; Michael R Hamblin
Journal: Nanoscale Date: 2017-01-26 Impact factor: 7.790

3. Using SV119-gold nanocage conjugates to eradicate cancer stem cells through a combination of photothermal and chemo therapies.

Authors: Tianmeng Sun; Yi Wang; Yucai Wang; Jinbin Xu; Xin Zhao; Suwanna Vangveravong; Robert H Mach; Younan Xia
Journal: Adv Healthc Mater Date: 2014-03-26 Impact factor: 9.933

4. Sigma receptors [σRs]: biology in normal and diseased states.

Authors: Colin G Rousseaux; Stephanie F Greene
Journal: J Recept Signal Transduct Res Date: 2015-06-09 Impact factor: 2.092

Review 5. Phase-Change Materials for Controlled Release and Related Applications.

Authors: Jichuan Qiu; Da Huo; Younan Xia
Journal: Adv Mater Date: 2020-05-08 Impact factor: 30.849

Review 6. Nanoplatforms for Targeted Stimuli-Responsive Drug Delivery: A Review of Platform Materials and Stimuli-Responsive Release and Targeting Mechanisms.

Authors: Yuzhe Sun; Edward Davis
Journal: Nanomaterials (Basel) Date: 2021-03-16 Impact factor: 5.076